2-[(2S)-2-carboxypyrrolidin-1-yl]-1-methyl-2-oxoethylamidophosphate

ID: ALA1161022

Max Phase: Preclinical

Molecular Formula: C8H15N2O6P

Molecular Weight: 266.19

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  C[C@@H](NP(=O)(O)O)C(=O)N1CCC[C@H]1C(=O)O

Standard InChI:  InChI=1S/C8H15N2O6P/c1-5(9-17(14,15)16)7(11)10-4-2-3-6(10)8(12)13/h5-6H,2-4H2,1H3,(H,12,13)(H3,9,14,15,16)/t5-,6+/m1/s1

Standard InChI Key:  UGGHNDGDVCUWQX-RITPCOANSA-N

Molfile:  

     RDKit          2D

 18 18  0  0  0  0  0  0  0  0999 V2000
    4.2542   -1.9417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8417   -1.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7542   -0.5000    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -1.2167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0792   -2.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1792   -1.2167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.6417   -1.4250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1667    0.2208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -0.0875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.0417   -0.9042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.2542   -0.5042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.4042   -0.6292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9292   -2.7000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.4500   -1.6042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -0.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2500   -2.8292    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5500   -3.2500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0167   -2.0417    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  6  1  0
  4  2  1  0
  5  1  1  0
  6  4  1  0
  5  7  1  6
  8  3  1  0
  9  3  1  0
 10  3  2  0
 11  2  2  0
 12  7  2  0
 13  1  1  0
 14  7  1  0
  4 15  1  1
 16  5  1  0
 17 13  1  0
  4 18  1  0
 17 16  1  0
M  END

Alternative Forms

  1. Parent:

    ALA1161022

    ---

Associated Targets(Human)

ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 266.19Molecular Weight (Monoisotopic): 266.0668AlogP: -0.87#Rotatable Bonds: 4
Polar Surface Area: 127.17Molecular Species: ACIDHBA: 3HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 2.82CX Basic pKa: CX LogP: -1.59CX LogD: -8.04
Aromatic Rings: Heavy Atoms: 17QED Weighted: 0.49Np Likeness Score: 0.05

References

1. Andrews PR, Carson JM, Caselli A, Spark MJ, Woods R..  (1985)  Conformational analysis and active site modelling of angiotensin-converting enzyme inhibitors.,  28  (3): [PMID:2983076] [10.1021/jm00381a021]

Source